Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8485710 | Vaccine | 2018 | 5 Pages |
Abstract
The 2012-2013 national serosurvey showed levels of rubella-specific IgG seropositivity in the Australian population are relatively high with no evidence of decrease compared to previous serosurveys conducted in 1996-1999, 2002 and 2007. The lower proportion of seropositive males aged 30-44â¯years likely reflects the initial immunisation program targeting females only. To our knowledge this study represents the longest period of serosurveillance following introduction of a nationally funded rubella immunisation program. The lack of evidence of decreasing rubella-specific IgG seropositivity is therefore reassuring for Australia and other countries with longstanding high vaccine coverage.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Chathura Edirisuriya, Frank H. Beard, Alexandra J. Hendry, Aditi Dey, Heather F. Gidding, Linda Hueston, Dominic E. Dwyer, James G. Wood, Kristine K. Macartney, Peter B. McIntyre,